(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression
Year: 2020
Type: article
Institutions: The University of Osaka, Global Center for Medical Engineering and Informatics, The University of Osaka, Chiba University, Center for Forensic Mental Health, Chiba University, Kanazawa University, University of Fukui, Hamamatsu University School of Medicine, Institute for Open and Transdisciplinary Research Initiatives, Molecular Research Center for Children's Mental Development
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Takeda Science Foundation, Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology, Dainippon Sumitomo Pharma, Osaka University, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Otsuka Pharmaceutical, Chiba University, Japan Society for the Promotion of Science
Awards: Drug discovery research targeting the novel regulation of prefrontal dopaminergic system by the functional interaction between the sigma1 and serotonin1A receptors, Modelling psychiatric disorders with iPS technology and genetically engineered mice, G1515086623, A novel whole-brain imaging analysis for the pathogenesis and therapeutic mechanisms of psychiatric disorders, G2528120606, G2718267987, Development of single cell-based technologies for iPSC-neurons from patients with schizophrenia, G3512149557, Multiscale data analysis of brain disease models for brain disease elucidation and drug discovery, G5375198244, Modeling of psychiatric disorders using iPSC technologies, G6676166977, G756428506, G7661425196, Advanced Animal Model Support
OpenAlex ID: W3007355462
